- Home
- HHS vs PASG Comparison
HHS vs PASG Comparison
Compare HHS & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HHS | PASG |
|---|---|---|
| Founded | 1923 | 2017 |
| Country | United States | United States |
| Employees | N/A | 27 |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.7M | 14.8M |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | HHS | PASG |
|---|---|---|
| Price | $4.24 | $4.70 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | 9.0K | ★ 23.0K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 97.35 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $159,570,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.00 | $3.29 |
| 52 Week High | $4.32 | $20.00 |
Technical Indicators
Market Signals| Indicator | HHS | PASG |
|---|---|---|
| Relative Strength Index (RSI) | 85.20 | 45.74 |
| Support Level | $2.70 | $4.25 |
| Resistance Level | $4.32 | $4.75 |
| Average True Range (ATR) | 0.20 | 0.24 |
| MACD | 0.16 | 0.03 |
| Stochastic Oscillator | 90.60 | 60.00 |
Price Performance
Historical ComparisonAbout HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The company operates three business segments: Revenue Solutions; Customer Care; and Fulfillment & Logistics Services. It derives maximum revenue from Fulfillment & Logistics Services segment. The Fulfillment & Logistics Services segment includes printing, lettershop, advanced mail optimization (including commingling services), logistics and transportation optimization, monitoring and tracking, to support traditional and specialized mailings. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
About PASG Passage Bio Inc.
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.